Streetbeat News

RAPP

Rapport Therapeutics Inc.

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Open

20.91

Mkt cap

805M

Volume

16K

High

22.09

P/E Ratio

-11.18

52-wk high

29.74

Low

20.52

Div yield

N/A

52-wk low

16.55

Rapport Therapeutics has set its IPO price at $17 per share for 8 million shares, with an initial trading price indicating $18.05 on 350,819 shares.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 2:58 pm

Rapport Therapeutics has set its IPO price at $17 per share, with 8 million shares being offered. The IPO price indicates a potential value of $18 per share on 276,000 shares.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 2:42 pm

Rapport Therapeutics has set its IPO price at $17 per share for 8 million shares, with an indication of $18 per share on 196,335 shares.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 2:33 pm

Rapport Therapeutics is set to price its IPO at $18 per share, with 163,000 shares being offered.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 2:24 pm

Rapport Therapeutics has set its IPO price at $18 per share, with an offering of 8 million shares priced at $17 each.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 2:01 pm

Trading halt status for an IPO security was updated at 9:50:00 AM ET, and the security has been released for quotation.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 1:50 pm

Rapport Therapeutics has priced its initial public offering (IPO) of 8 million shares at $17 per share.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 7:10 am

Rapport Therapeutics, Inc (NASDAQ:RAPP) is set to IPO on June 07 on the NASDAQ exchange with shares priced between $16.00 and $18.00. The company focuses on developing small molecule medicines for CNS disorders.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 3:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.